Tuesday, February 10th, 2015 at 11:34 AM
A recently concluded research study at Brigham and Women’s Hospital in Boston has revealed that many firefighters may have undiagnosed sleep disorders.
Researchers examined nearly 7,000 firefighters from 66 fire departments across the United States. Of those, 37% suffered from a sleep disorder, such as sleep apnea, insomnia, shift-work disorder and restless leg syndrome.
“These firefighters have also been found prone to car accidents or to have fallen asleep while driving”, the study findings have recorded. Chronic health issues such as heart disease, diabetes, depression and anxiety also have large probability among these firefighters, according to the research revelations. Read the rest of this entry
Wednesday, December 21st, 2011 at 9:20 PM
Sleep disorders often remain undiagnosed. Untreated sleep disorders among police officers may adversely affect their health and safety and pose a risk to the public.
Researchers examined and evaluated associations between sleep disorder risk and self-reported health, safety, and performance outcomes in police officers.
Cross-sectional and prospective cohort study of North American police officers participating in either an online or an on-site screening (n=4957) and monthly follow-up surveys (n=3545 officers representing 15 735 person-months) between July 2005 and December 2007. A total of 3693 officers in the United States and Canada participated in the online screening survey, and 1264 officers from a municipal police department and a state police department participated in the on-site survey. Read the rest of this entry
Friday, May 6th, 2011 at 11:15 PM
SleepApneaDisorder/[ Press Release ]/ FRAZER, Pa./ May 6, 2011 / At the Society of General Internal Medicine’s 34th Annual Meeting in Phoenix, Ariz. today, Cephalon, Inc. presented positive results from a phase IV trial of nearly 400 people with excessive sleepiness associated with shift work disorder. In the trial, NUVIGIL® (armodafinil) Tablets [C-IV] improved shift-workers’ overall clinical condition late in their shifts (i.e., 4:00 a.m. to 8:00 a.m.), including the commute home, compared to placebo. The key secondary endpoint of the study was to assess global function, as measured by the Global Assessment of Functioning (GAF), and patients taking NUVIGIL experienced a greater improvement in GAF score compared to those patients taking placebo. Shift work disorder occurs when the body’s internal sleep-wake clock is out of sync with the individual’s work schedule – their bodies tell them to go to sleep when their work schedule needs them to stay awake. The primary symptoms of shift work disorder are excessive sleepiness and insomnia. Read the rest of this entry
Sunday, October 24th, 2010 at 8:29 PM
SleepApneaDisorder/[Press Release ] / Cephalon, Inc. today announced that Risk Evaluation and Mitigation Strategies (REMS) for its medications NUVIGIL® (armodafinil) Tablets [C-IV] and PROVIGIL® (modafinil) Tablets [C-IV] have been approved by the U.S. Food and Drug Administration (FDA). Both the NUVIGIL and PROVIGIL REMS consist of a Medication Guide to inform patients about the potential risks associated with the use of these medications, a communication plan and a timetable for submission of assessments of the REMS. The communication plan includes a Dear Healthcare Professional Letter, a Prescriber Brochure, a Pharmacist Action Letter and a dedicated REMS Internet Site. The introduction of the NUVIGIL and PROVIGIL REMS programs is consistent with the company’s commitment to safe and appropriate use of its medications. Read the rest of this entry